Table 2 Baseline Costs for a Pharmacoeconomic Model of Vasomotor Symptoms
From: Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
Drug acquisition costs | Â |
|---|---|
   Norethindrone acetate/ethinyl estradiol | $357 |
   Conjugated estrogen/medroxyprogesterone | $474 |
Therapy initiation | Â |
   Two physician visits | $132 |
Breakthrough bleeding at 3 months (or continued spotting at 6 months) | Â |
   Endometrial biopsy | $198 |
   Pathology and laboratory fees | $147 |
Telephone call to physician | Â |
   Spotting at 3 months | $16 |
Moderate to severe vasomotor symptoms | Â |
   Two physician visits | $132 |
   90-day supply of clonidine | $31 |